Filana Therapeutics (FLNA) Free Cash Flow by Year
Filana Therapeutics, Inc. recorded an outflow of $32.8M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Filana Therapeutics, Inc. has filed alongside them.
Ticker history: SAVA became FLNA (Filana Therapeutics, Inc.) on . Earlier news and filings retain their original names and dates. View SAVA history.
Annual figures, oldest first. Point at a bar to read its period.
FLNA Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
FLNA Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Filana Therapeutics, Inc. financials
Frequently Asked Questions
Filana Therapeutics, Inc. recorded an outflow of $32.8M in free cash flow in fiscal year 2025.
Filana Therapeutics, Inc. (FLNA) reported an outflow of $117.0M in free cash flow in fiscal year 2024 and an outflow of $32.8M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Filana Therapeutics, Inc. (FLNA) reported -$3.9M in free cash flow in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Filana Therapeutics, Inc. (FLNA) reported on that line in every period on record.